This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Thalassemia
and you are
between 18 and 50
years old
Phase
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to determine the efficacy of antioxidant cocktails on the alleviation of oxidative stress and iron overload in beta-thalassemia/Hb E patients.

Provided treatments

  • Drug: curcuminoids, N-acetylcysteine, deferiprone and vitamin E
  • Drug: Curcuminoids and alpha-tocopherol
Tris trial is registered with FDA with number: NCT01597765. The sponsor of the trial is Mahidol University and it is looking for 60 volunteers for the current phase.
Official trial title:
Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients